News Focus
News Focus
Followers 3160
Posts 967885
Boards Moderated 152
Alias Born 09/04/2000

Re: mick post# 228671

Monday, 01/18/2021 2:14:33 PM

Monday, January 18, 2021 2:14:33 PM

Post# of 246423
USE TO BE HAMBURGER JOINT WIT BIG BUST !!!!!
https://www.sonnetbio.com/
NEW 01-16-20021
$SONN DOES MOVE QUICKLY
https://investorshub.advfn.com/Sonnet-BioTherapeutics-Inc-SONN-12130/
$SONN This study is an important milestone for SON-1010, and we believe further validates the fundamental strengths of our drug development platform."

Sonnet BioTherapeutics Announces the Completion of a Successful Non-Human Primate Study of SON-1010
Mon, November 30, 2020, 6:30 AM MST
Compared to recombinant human IL-12, SON-1010 demonstrated an enhanced pharmacokinetic (PK) profile that was similar to IgG antibodies

SON-1010 continues to be well tolerated at doses far exceeding levels expected in potential future clinical trials, without producing detectable cytokine imbalances

Analysis of Interferon-? levels, a key biomarker of antitumor activity, suggest potent on-target pharmacodynamic (PD) effects

UPDATE 08-24-2020
$SONN APPRECIATE EMERGENCY PLASMA AUTHORIZATION 08-24-2020

RE
JUST IN: $SONN 3 Penny Stocks To Watch After Trump's Emergency Plasma Authorization

Convalescent Plasma Stocks To Watch Penny stocks shift in an instant and that could be the case for a few companies this week.

Over the weekend, U.S. President Donald Trump announced the emergency authorization of convalescent plasma for COVID-19.

https://www.sonnetbio.com/news-media/press-releases
Nov 30, 2020 8:30am EST
Sonnet BioTherapeutics Announces the Completion of a Successful Non-Human Primate Study of SON-1010
Sep 01, 2020 8:30am EDT
Sonnet Announces New Preclinical Data for SON-1010 (Interleukin 12-F(H)AB)

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today